Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73,543 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of Low-Dose Radiation Therapy on Abscopal Responses to Hypofractionated Radiation Therapy and Anti-PD1 in Mice and Patients With Non-Small Cell Lung Cancer.
Yin L, Xue J, Li R, Zhou L, Deng L, Chen L, Zhang Y, Li Y, Zhang X, Xiu W, Tong R, Gong Y, Huang M, Xu Y, Zhu J, Yu M, Li M, Lan J, Wang J, Mo X, Wei Y, Niedermann G, Lu Y. Yin L, et al. Among authors: xu y. Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):212-224. doi: 10.1016/j.ijrobp.2020.05.002. Epub 2020 May 15. Int J Radiat Oncol Biol Phys. 2020. PMID: 32417411
Secondary Infections After Diagnosis of Severe Radiation Pneumonitis (SRP) Among Patients With Non-Small Cell Lung Cancer: Pathogen Distributions, Choice of Empirical Antibiotics, and the Value of Empirical Antifungal Treatment.
Mei T, Yang X, Yu Y, Tian X, Deng Q, Xu Y, Zhou L, Zhou X, Liu Y, Zou B, Xue J, Quan M, Yan L, Lu Y, Gong Y. Mei T, et al. Among authors: xu y. Int J Radiat Oncol Biol Phys. 2022 Jan 1;112(1):179-187. doi: 10.1016/j.ijrobp.2021.08.022. Epub 2021 Aug 19. Int J Radiat Oncol Biol Phys. 2022. PMID: 34418467
Comparison of chemotherapy plus bevacizumab vs. chemotherapy alone as third-line treatment or beyond for advanced non-small cell lung cancer: A propensity score-matched analysis.
Hu B, Zhou X, Liu Y, Li Q, Xiang M, Zou B, Peng F, Huang M, Gong Y, Zhu J, Wang Y, Ren L, Xu Y, Zhang Y, Li Y, Yu M, Xue J, Deng L, Wang J, Ding Z, Lu Y. Hu B, et al. Among authors: xu y. Oncol Lett. 2018 Apr;15(4):5671-5679. doi: 10.3892/ol.2018.8064. Epub 2018 Feb 15. Oncol Lett. 2018. PMID: 29556304 Free PMC article.
Monitoring the estimated glomerular filtration rate (eGFR) in patients with small-cell lung cancer during chemotherapy: equations based on serum creatinine or cystatin C?
Tian X, Zhang X, Yu M, Lu Y, Ding Z, Huang M, Peng F, Ren L, Wang J, Wang Y, Xu Y, Zhu J, Zhou L, Zhou X, Deng M, Tang X, Gong Y. Tian X, et al. Among authors: xu y. Int J Clin Oncol. 2018 Apr;23(2):258-265. doi: 10.1007/s10147-017-1206-y. Epub 2017 Nov 4. Int J Clin Oncol. 2018. PMID: 29103151
Concurrent brain radiotherapy and EGFR-TKI may improve intracranial metastases control in non-small cell lung cancer and have survival benefit in patients with low DS-GPA score.
Liu Y, Deng L, Zhou X, Gong Y, Xu Y, Zhou L, Wan J, Zou B, Wang Y, Zhu J, Ding Z, Peng F, Huang M, Ren L, Lautenschlaeger T, Kong FS, Lu Y. Liu Y, et al. Among authors: xu y. Oncotarget. 2017 Nov 30;8(67):111309-111317. doi: 10.18632/oncotarget.22785. eCollection 2017 Dec 19. Oncotarget. 2017. PMID: 29340055 Free PMC article.
Predicting severe acute radiation pneumonitis in patients with non-small cell lung cancer receiving postoperative radiotherapy: Development and internal validation of a nomogram based on the clinical and dose-volume histogram parameters.
Tang X, Li Y, Tian X, Zhou X, Wang Y, Huang M, Ren L, Zhou L, Xue J, Ding Z, Zhu J, Xu Y, Peng F, Wang J, Lu Y, Gong Y. Tang X, et al. Among authors: xu y. Radiother Oncol. 2019 Mar;132:197-203. doi: 10.1016/j.radonc.2018.10.016. Epub 2018 Oct 29. Radiother Oncol. 2019. PMID: 30385172
Progression of Central Nervous System Metastases in Advanced Nonsmall Cell Lung Cancer Patients Effectively Treated with First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor.
Yu M, Zhao Q, Li Y, Zhang S, Xu Y, Gong Y, Zhu J, Ding Z, Wang J, Peng F, Wang Y, Huang M, Ren L, Lu Y, Liu Y. Yu M, et al. Among authors: xu y. Cancer Biother Radiopharm. 2018 Dec;33(10):421-426. doi: 10.1089/cbr.2018.2493. Cancer Biother Radiopharm. 2018. PMID: 31050549
73,543 results
You have reached the last available page of results. Please see the User Guide for more information.